TFX vs. GMED, PODD, BAX, RMD, PEN, SOLV, SWAV, GKOS, INSP, and HAE
Should you be buying Teleflex stock or one of its competitors? The main competitors of Teleflex include Globus Medical (GMED), Insulet (PODD), Baxter International (BAX), ResMed (RMD), Penumbra (PEN), Solventum (SOLV), Shockwave Medical (SWAV), Glaukos (GKOS), Inspire Medical Systems (INSP), and Haemonetics (HAE). These companies are all part of the "surgical & medical instruments" industry.
Globus Medical (NYSE:GMED) and Teleflex (NYSE:TFX) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation, community ranking and earnings.
Globus Medical has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500. Comparatively, Teleflex has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500.
Teleflex has higher revenue and earnings than Globus Medical. Teleflex is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.
In the previous week, Teleflex had 1 more articles in the media than Globus Medical. MarketBeat recorded 15 mentions for Teleflex and 14 mentions for Globus Medical. Globus Medical's average media sentiment score of 0.81 beat Teleflex's score of 0.73 indicating that Teleflex is being referred to more favorably in the news media.
Globus Medical currently has a consensus target price of $66.50, suggesting a potential upside of 3.26%. Teleflex has a consensus target price of $261.75, suggesting a potential upside of 20.27%. Given Globus Medical's stronger consensus rating and higher possible upside, analysts clearly believe Teleflex is more favorable than Globus Medical.
Teleflex has a net margin of 9.82% compared to Teleflex's net margin of 3.51%. Globus Medical's return on equity of 14.78% beat Teleflex's return on equity.
Globus Medical received 27 more outperform votes than Teleflex when rated by MarketBeat users. Likewise, 67.79% of users gave Globus Medical an outperform vote while only 59.54% of users gave Teleflex an outperform vote.
95.2% of Globus Medical shares are held by institutional investors. Comparatively, 95.6% of Teleflex shares are held by institutional investors. 24.3% of Globus Medical shares are held by company insiders. Comparatively, 1.4% of Teleflex shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
Teleflex beats Globus Medical on 12 of the 17 factors compared between the two stocks.
Get Teleflex News Delivered to You Automatically
Sign up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TFX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Teleflex Competitors List
Related Companies and Tools
